Ireland - English - HPRA (Health Products Regulatory Authority)

gilead sciences international - amphotericin b - concentrate for soln for inf - 50 milligram - antibiotics

Australia - English - Department of Health (Therapeutic Goods Administration)

gilead sciences pty ltd - amphotericin b, quantity: 50 mg - injection, powder for - excipient ingredients: hydrogenated soy phosphatidylcholine; sucrose; dl-alpha-tocopherol; distearoylphosphatidylglycerol; sodium succinate; cholesterol - indications: ambisome is indicated for: prophylaxis in liver transplant patients at risk of systemic candida, aspergillus and cryptococcus infections, and for the treatment of systemic fungal infections caused by organisms susceptible to amphotericin b (see clinical trials). ambisome is indicated for the treatment of visceral leishmaniasis. clinical studies of efficacy in visceral leishmaniasis are limited to leishmania infantum. indicated as at 8 september 2003 :ambisome is indicated for: prophylaxis in liver transplant patients at risk of systemic candida, aspergillus and cryptococcus infections, and for the treatment of systemic fungal infections caused by organisms susceptible to amphotericin b (see clinical trials). ambisome is indicated for empirical treatment of presumed fungal infections in febrile neutropaenic patients whose fever has failed to respond to broad spectrum antibiotic treatment. ambisome is indicated for the treatment of visceral leishmaniasis. clinical studies of efficacy in visceral leishmaniasis are limited to leishmania infantum.

Ireland - English - HPRA (Health Products Regulatory Authority)

gilead sciences ireland uc - amphotericin b - concentrate for solution for infusion - 50 milligram(s) - antibiotics; amphotericin b

Ireland - English - HPRA (Health Products Regulatory Authority)

healthilife limited - oenothera biennis soya oil lecithinum soya fat emulsions tocopherol iron pyridoxine hydrochloride ascorbic acid zinc heavy magnesium oxide chromium - capsule

Ireland - English - HPRA (Health Products Regulatory Authority)

healthilife limited - calcium caseinate soya protein fructose flavour protein hydrolysate lecithinum soya -

Ireland - English - HPRA (Health Products Regulatory Authority)

rowa pharmaceuticals limited - melissa extract eugenol lecithinum soya -

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - cytarabine 100 mg/ml;   - solution for injection - 100 mg/ml - active: cytarabine 100 mg/ml   excipient: hydrochloric acid sodium hydroxide water for injection - cytarabine may be used alone or in combination with other chemotherapeutic agents. it is indicated for induction of remission of leukaemia, particularly for acute myeloid leukaemia, in adults and children. cytarabine has been used for remission induction in acute lymphocytic leukaemia, chronic myeloid leukaemia and erythroleukaemia; and in the treatment and maintenance therapy of meningeal leukaemia and other meningeal neoplasms.

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare limited - valganciclovir hydrochloride - film coated tablet - 450 milligram - valganciclovir

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - amphotericin b phospholipid complex - suspension for infusion - 5mg/1ml

Malta - English - Medicines Authority

accord healthcare limited - valaciclovir hydrochloride - film-coated tablet - valaciclovir hydrochloride 450 mg - antivirals for systemic use